Call Us : 08045477764
The management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention of post-operative nausea and vomiting in adults. Paediatric Population: Ondansetron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged 6 months.